Showing results (1841-1850 of 1,899) with videos related to

Sort By:
Pageof 190
Immunotherapy|October 16, 2023
Secukinumab in the treatment of hidradenitis suppurativaCorey L Snyder, Ruby S Gibson, Martina L Porter, et al.
Immunotherapy|September 29, 2023
Tezepelumab for the treatment of severe asthma: a plain language summary of the PATHWAY and NAVIGATOR studiesJonathan Corren, Andrew Menzies-Gow, Johan Bimmel, et al.
Immunotherapy|September 20, 2023
Safety and effectiveness of a 300 IR house dust mite sublingual tablet: descriptive 4-year final analysis of a post-marketing surveillance in JapanYoshitaka Okamoto, Moe Kato, Kiyonori Ishii, et al.
Immunotherapy|September 18, 2023
Adenovirus-induced hemorrhagic cystitis after CD19-targeted chimeric antigen receptor T-cell therapy in a patient with large B-cell lymphomaIrene Medina, Cecilia Carpio, Isabel Ruiz-Camps, et al.
Immunotherapy|September 13, 2024
The association between toxicity and efficacy of immune checkpoint inhibitors in older adults with NSCLCYiran Rong, Sujith Ramachandran, Kaustuv Bhattacharya, et al.
Immunotherapy|September 12, 2024
Profiling of autoantibodies in the sera of glioblastoma patientsJohannes Low Jun Wei, Ammar Akram Kamarudin, Bee Hong Soon, et al.
Immunotherapy|September 12, 2024
A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumorsBen Tran, Mark Voskoboynik, Johanna Bendell, et al.
Immunotherapy|October 8, 2024
Allogeneic CAR-T cells for cancer immunotherapyXinfeng Chen, Yaoxin Gao, Yi Zhang
Immunotherapy|October 17, 2024
Hemophagocytic lymphohistiocytosis in a patient with Epstein-Barr virus-positive diffuse large B-cell lymphoma treated with chimeric antigen receptor T-cell therapyAna Maria Meireles, Gloria Iacoboni, Leonardo Maia Moço, et al.
Immunotherapy|May 31, 2023
Neoadjuvant immunotherapy plus chemotherapy and adjuvant targeted therapy in ALK-positive non-small-cell lung cancerQi Song, Jie Li, Qi Xiong, et al.
Pageof 190